<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="120945">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528280</url>
  </required_header>
  <id_info>
    <org_study_id>CEPE2012FRuiz</org_study_id>
    <nct_id>NCT01528280</nct_id>
  </id_info>
  <brief_title>Humoral and Cellular Response in Shift Workers</brief_title>
  <official_title>Vaccination Against Hepatitis A Virus in Shift Workers: Evaluation of the Humoral and Cellular Immune Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to access whether shift workers (morning, afternoon or night)
      vaccinated against hepatitis A would have some humoral and cellular response impairment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sleep regulates immune functions. In this sense, we asked whether shift workers (morning,
      afternoon or night) vaccinated against hepatitis A would have some humoral and cellular
      response impairment. Men (18 to 55 years) will be recruited through different forms of media
      (electronic, newspapers, radio and magazines). The shift workers sleep pattern will be
      recorded polysomnographically. Subsequently, the volunteers will be underwent vaccination
      against hepatitis A (2 doses) and after 30, 60 and 90 days, blood samples will be collected
      to assess the humoral response in the experimental groups. The hormones prolactin, growth
      hormone, cortisol, adrenaline and noradrenaline will also be evaluated. Indeed, stimulations
      in culture will be conducted to assess the cellular response profile against the vaccination
      through the production assessment of IL-4, IFN-γ, IL-2 and TNF-α.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antibodies against hepatitis A virus (anti-HAV)</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in antibodies against hepatitis A virus (anti-HAV) production</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intracellular cytokines</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in intracellular IL-4, IFN-γ, IL-2 e TNF-α cytokine levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catecholamines</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in cathecolamines levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolactin</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in prolactin levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth hormone</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in growth hormone levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol</measure>
    <time_frame>Baseline, 30 days, 60 days and 90 days</time_frame>
    <description>Change in cortisol levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep disorders</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessment of sleep disorders</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Other Condition That May be a Focus of Clinical Attention</condition>
  <arm_group>
    <arm_group_label>Shiftwork</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The comparision will consider nightworkers versus dayworkers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccination against hepatitis A</intervention_name>
    <description>Vaccination against hepatitis A (2 doses) into the deltoid muscle of the nondominant arm twice, i.e., at 0 and 6 months.</description>
    <arm_group_label>Shiftwork</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>No Intervention</description>
    <arm_group_label>Shiftwork</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  shift workers

          -  naive immune status against hepatitis A confirmed by hepatitis A virus (HAV)
             antibodies levels below 5 mIU/mL

        Exclusion Criteria:

          -  smokers

          -  individuals with complaints and/or sleep disorders

          -  acute or chronic disease

          -  use of medication during the study period.

          -  acute illnesses
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Tulio Mello, Associate Professor</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francieli Silva Ruiz, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Maculano, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Tulio Mello, PhD</last_name>
    <phone>+55 11 55720177</phone>
    <email>tmello@demello.net.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francieli Silva Ruiz, PhD</last_name>
    <phone>+55 11 55720177</phone>
    <email>francieli.ruiz@cepebr.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro de Estudos em Psicobiologia e Exercicio _ CEPE</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04020050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Mello, PhD</last_name>
      <phone>551155720177</phone>
      <email>tmello@demello.net.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Estudos em Psicobiologia e Exercicio - CEPE</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04020050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Tulio Mello, PhD</last_name>
      <phone>+55 11 55720177</phone>
      <email>tmello@demello.net.br</email>
    </contact>
    <investigator>
      <last_name>Francieli Silva Ruiz, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Maculano, Postdoc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.unifesp.br/dpsicobio/</url>
    <description>Psychobiology Department of Federal University of Sao Paulo</description>
  </link>
  <link>
    <url>http://www.cepebr.org/home.asp</url>
    <description>Centro de Estudos em Psicobiologia e Exercício</description>
  </link>
  <link>
    <url>http://www.fapesp.br/</url>
    <description>Fundação de Amparo à Pesquisa do Estado de São Paulo</description>
  </link>
  <verification_date>August 2014</verification_date>
  <lastchanged_date>August 11, 2014</lastchanged_date>
  <firstreceived_date>February 2, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Marco Tulio de Mello</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Shift work</keyword>
  <keyword>Hepatitis A vaccination</keyword>
  <keyword>humoral response</keyword>
  <keyword>cellular response</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
